This HTML5 document contains 147 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.3109/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45938776
rdf:type
wikibase:Item
schema:description
article scientifique (publié 2012) artigo científico articolo scientifico 2012年學術文章 naučni članak мақолаи илмӣ artículu científicu научна статия artigo científico (publicado na 2012) videnskabelig artikel (udgivet 2012) bilimsel makale سائنسی مضمون ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年学术文章 מאמר מדעי tieteellinen artikkeli artikull shkencor wissenschaftlicher Artikel artykuł naukowy vitenskapelig artikkel 2012年の論文 bài báo khoa học wetenschappelijk artikel 2012年學術文章 2012 nî lūn-bûn vědecký článek 2012年學術文章 სამეცნიერო სტატია mokslinis straipsnis articol științific 2012年学术文章 научная статья наукова стаття, опублікована в жовтні 2012 2012年學術文章 επιστημονικό άρθρο vitskapeleg artikkel 2012年学术文章 artikulong pang-agham vetenskaplig artikel 2012年學術文章 บทความทางวิทยาศาสตร์ 2012년 논문 scientific article tudományos cikk article científic scienca artikolo مقالة علمية գիտական հոդված artículo científico publicado en 2012 artigo científico (publicado na 2012) мақолаи илмӣ 2012年学术文章 مقالهٔ علمی научни чланак article scientific 2012年学术文章 научни чланак teaduslik artikkel 2012年學術文章 vedecký článok
p:P577
wds:Q45938776-12B75155-EEA6-401C-AF70-B082EEDE7E15
wdt:P577
2012-10-26T00:00:00Z
p:P2860
wds:Q45938776-114A1F1A-5ED2-4071-B41A-862F2CAAC7D8 wds:Q45938776-0DC94FB7-C5AB-4C1E-876F-FEA83E9C46CC wds:Q45938776-1FAB8DB1-2967-4EF5-B2AA-84AC3E86A24D wds:Q45938776-8A7EC4A0-6DB1-48CC-BFD1-7B787BFACC4D wds:Q45938776-6CB293C6-5586-4A3B-87B7-4AD31DA4DD2B wds:Q45938776-A8F7B5CE-2938-443C-871D-7E519263B639 wds:Q45938776-F5CC9E53-9FF1-4F32-BB4D-FCAEFD483E1B wds:Q45938776-DD9336F3-8057-4D5F-81BB-A4DF59CF993F
wdt:P2860
wd:Q35012157 wd:Q35954629 wd:Q37089685 wd:Q36517701 wd:Q34462557 wd:Q58204776 wd:Q28295371 wd:Q40010153
p:P2093
wds:Q45938776-ACEED6E0-36BF-4E07-A18D-051FD27085D6 wds:Q45938776-8C082799-1048-4850-82DE-AB1D874F0A2E wds:Q45938776-A5F17952-0EF8-4E85-8C89-57EEC37EBFC6 wds:Q45938776-C4CA0369-5202-4EE6-9A1F-72415FA9A2DD wds:Q45938776-CB330794-2DB1-4EF7-8727-1B68078911B8 wds:Q45938776-C48C3351-9F0A-45DA-9A5B-CAB97C9FB043 wds:Q45938776-F2537EEA-013A-4A25-960C-9C2E51095727 wds:Q45938776-F4CB50E3-EFE5-456D-9579-B9FE33FC796B wds:Q45938776-2E9F7569-8F74-4BC2-8E14-CFC6873A7B79 wds:Q45938776-3E1C2382-2FFA-41A2-A927-1BE0B8BD657D wds:Q45938776-43E0D0FA-7D38-46BD-9D15-4EDDC5090EFA wds:Q45938776-6D14A3B4-5A06-44B4-8622-F9EC083554DA wds:Q45938776-867C091A-FC60-42FB-B1C3-D8FDA16521F6 wds:Q45938776-650180D2-848D-4F8A-8835-3098858712BB wds:Q45938776-86CC9EBF-FB3C-4189-AAEF-3179ADEF9B77 wds:Q45938776-87B9D388-007C-46F1-B97A-5A69386A612D wds:Q45938776-03F03EE2-854E-4686-8F7A-E059DCDB4A11 wds:Q45938776-0DDFED55-C8A6-4499-8D44-E6C6AF987175 wds:Q45938776-09567660-9D71-4060-8BC4-51A5E92A4C66 wds:Q45938776-1A8BE4CC-C2AA-4328-897B-9D441C3BBB20 wds:Q45938776-1D4A3705-D873-4198-9884-901C4E12BFCD
wdt:P2093
Daizo Kato Yosuke Hattori Toshihisa Kojima Koji Funahashi Hiroyuki Miyake Tomone Shioura Takefumi Kato Hiroyuki Matsubara Hiroki Tsuchiya Yuji Hirano Naoki Ishiguro Kenya Terabe Nobuyuki Asai Hisato Ishikawa Masatoshi Hayashi Daihei Kida Tsuyoshi Wanatabe Hideki Takagi Atsushi Kaneko Nobunori Takahashi Yuichiro Yabe
rdfs:label
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis. Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
skos:prefLabel
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis. Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
schema:name
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis. Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
p:P1476
wds:Q45938776-58E353D5-6F32-4260-981C-7E2BF12773A5
wdt:P1476
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
p:P304
wds:Q45938776-06D244EC-F110-4EE0-A83D-688DF4620FD2
wdt:P304
977-985
p:P31
wds:Q45938776-5E1F50D2-0A1D-4708-8BC1-5F6A5B108557
wdt:P31
wd:Q13442814
p:P921
wds:Q45938776-5650DA86-9B63-40A3-8735-E891F6C6F844
wdt:P921
wd:Q425154
p:P698
wds:Q45938776-1F4637AE-2FC1-46DE-BDE2-45FA210B710D
wdtn:P698
n11:23099471
wdt:P698
23099471
p:P1433
wds:Q45938776-8B572903-BADC-4FD0-B78C-1CADCD9DEF77
wdt:P1433
wd:Q15752709
p:P433
wds:Q45938776-E4DC7D2F-CDE6-4A9C-95F4-6D6757A27D42
p:P478
wds:Q45938776-E006F871-3CAF-4DB6-B761-F3DF094F30FF
wdt:P433
5
wdt:P478
23
p:P356
wds:Q45938776-C019A891-CF3D-47CA-AEFD-27EB52E4BDF2
wdtn:P356
n8:S10165-012-0782-Y
wdt:P356
10.3109/S10165-012-0782-Y